8-K: FIGS Inc. Announces Q2 2024 Results and $50 Million Share Repurchase Program

FIGS, Inc. reported its second quarter 2024 financial results, exceeding expectations, and authorized a $50 million share repurchase program.

Summary

• FIGS, Inc. announced its financial results for the second quarter of 2024, with net revenues reaching $144.2 million, a 4.4% increase year-over-year.
• Gross margin decreased to 67.4%, down 2.1% year-over-year, due to a shift in product mix.
• Operating expenses rose to $95.7 million, a 7.0% increase year-over-year, primarily due to higher selling and marketing costs.
• Net income was $1.1 million, or $0.01 per diluted share, a decrease of $3.5 million compared to the same period last year.
• Adjusted EBITDA was $12.9 million, a decrease of $6.0 million year-over-year.
• The company's active customer base grew by 6.1% year-over-year to 2.6 million.
• Net revenue per active customer was $210, a decrease of 2.3% year-over-year.
• Average order value (AOV) was $113, a decrease of 1.7% year-over-year.
• FIGS has authorized a share repurchase program of up to $50 million of its Class A common stock.
• The company expects full-year 2024 net revenue growth to be flat to 2% and adjusted EBITDA margin to be between 9.5% and 10%.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to exceeding revenue and EBITDA expectations, but there are concerns about declining margins and profitability. The share repurchase program is a positive sign, but the company faces challenges in maintaining growth and profitability.

Positives

• Net revenues increased by 4.4% year-over-year, reaching $144.2 million.
• The active customer base grew by 6.1% year-over-year to 2.6 million.
• The company exceeded its own outlook for both net revenues and adjusted EBITDA margin in Q2 2024.
• A $50 million share repurchase program was authorized, indicating confidence in the company's financial position.
• The company saw a positive year-over-year repeat frequency trend.

Negatives

• Gross margin decreased by 2.1% year-over-year to 67.4%.
• Net income decreased by $3.5 million year-over-year to $1.1 million.
• Adjusted EBITDA decreased by $6.0 million year-over-year to $12.9 million.
• Net revenue per active customer decreased by 2.3% year-over-year to $210.
• Average order value decreased by 1.7% year-over-year to $113.

Risks

• The company's ability to maintain historical growth rates is uncertain.
• Maintaining profitability is a key challenge for the company.
• The company faces risks related to brand reputation and customer retention.
• The company's reliance on a limited number of third-party suppliers poses a risk.
• Fluctuating raw material costs could impact profitability.
• The company is exposed to risks related to cyberattacks and data protection.
• The company's international expansion plans carry inherent risks.
• Macroeconomic trends and changes in consumer behavior could impact demand for the company's products.

Future Outlook

For the full year 2024, the company expects net revenue growth to be flat to 2% and adjusted EBITDA margin to be between 9.5% and 10%.

Management Comments

• Our strong second quarter performance shows that our investments are paying off, said Trina Spear, Chief Executive Officer and Co-Founder.
• Both net revenues and adjusted EBITDA margin exceeded our outlook, and we saw continued momentum in the business, including a positive year-over-year repeat frequency trend.
• Our strategy of combining pioneering product innovation with powerful top of funnel marketing is resonating.
• We look forward to continuing our momentum into the second half of the year, spurred by the biggest and most exciting campaign we have ever done our first-of-its-kind partnership outfitting the Team USA Medical Team.
• Our strong financial profile and long-term business outlook give us the confidence to evolve our capital allocation strategy, said Ms. Spear.
• We believe we have sufficient liquidity and cash flow generation to both invest internally for growth and also return value to our shareholders through a share repurchase program.

Industry Context

The healthcare apparel market is competitive, and FIGS faces challenges in maintaining its growth and profitability. The company's focus on product innovation and marketing is aimed at differentiating itself from competitors. The share repurchase program signals confidence in the company's future prospects.

Comparison to Industry Standards

• FIGS's gross margin of 67.4% is relatively high compared to traditional apparel companies, but it is down year-over-year, indicating potential pricing or cost pressures.
• The company's growth in active customers at 6.1% year-over-year is a positive sign, but the decrease in net revenue per active customer and average order value suggests challenges in maintaining customer spending levels.
• Compared to other direct-to-consumer brands, FIGS's operating expenses as a percentage of net revenue at 66.4% is relatively high, indicating a need for improved efficiency.
• Companies like Lululemon and Nike, while not directly comparable in product, serve as benchmarks for direct-to-consumer brands with strong brand recognition and customer loyalty. FIGS needs to continue to build its brand and customer base to compete effectively.
• The share repurchase program is a common strategy for companies with strong cash flow, but it also indicates a potential lack of other high-return investment opportunities.

Stakeholder Impact

• Shareholders will benefit from the share repurchase program.
• Customers may see continued product innovation and marketing efforts.
• Employees may be impacted by the company's focus on efficiency and profitability.
• Suppliers may be affected by the company's efforts to manage costs.

Next Steps

• The company will continue its marketing campaign, including the Team USA Medical Team partnership.
• The company will execute its share repurchase program.
• The company will host a conference call to discuss the results.

Key Dates

Keywords

FIGS, healthcare apparel, financial results, share repurchase, net revenue, EBITDA, gross margin, active customers, average order value, operating expenses